Technical analysis of Insulet Corp. (PODD): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin ma...
Price Performance
| 1 month | +13.66% |
| 3 months | -10.27% |
| Year-to-date | -47.34% |
| 1 year | -52.18% |
| 3 years | -7.93% |
| 5 years | -52.02% |
| 10 years | +324.87% |
52-Week Range
| 52-week High | $354.88 |
| 52-week Low | $126.40 |
| Avg Volume (90d) | 1.6M |
Technical Indicators
| SMA 50 | $140.91 |
| SMA 200 | $178.80 |
| Beta | 1.47 |
| 30-day Volatility (annualised) | 27.3% |
| Price vs SMA 50 | +6.2% |
| Price vs SMA 200 | -16.3% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $284.24 | |
| 2026-01 | $255.81 | -10.0% |
| 2026-02 | $246.61 | -3.6% |
| 2026-03 | $209.84 | -14.9% |
| 2026-04 | $172.14 | -18.0% |
| 2026-05 | $144.94 | -15.8% |
| 2026-06 | $152.25 | +5.0% |
| 2026-07 | $165.35 | +8.6% |
| 2026-08 | $148.66 | -10.1% |
| 2026-09 | $130.47 | -12.2% |
| 2026-10 | $149.68 | +14.7% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-04 | $1.59 | $833M |
| 2026-08-05 | $1.47 | $787M |
| 2026-05-06 | $1.19 | $730M |
| 2026-02-18 | $1.47 | $769M |
| 2025-11-06 | $1.14 | $678M |
| 2025-08-07 | $0.92 | $614M |
| 2025-05-08 | $0.79 | $543M |
Price
| Price | $149.68 (closing price, October 30, 2026) |
| Market Cap | $10.4B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 27.98 |
| Price / Book | 7.29 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.67 |
| Current Ratio | 2.48 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 9.08 |